Sunshine Pharma (06887) announced interim results
- RevenueRMB10.8bn
- Net profitRMB-6.0bn
- Profit attributable to ownersRMB-6.0bn
- Revenue YoY-44.5%
- Net profit YoY-4222.3%
- Depreciation & amortisationHK$4.6bn
- Capital expenditureHK$-8.4bn
- Interest-bearing debtHK$46.8bn
Source Sunshine Pharma



